Overview of the 2022 WHO Classification of Parathyroid Tumors

The 2022 WHO classification reflects increases in the knowledge of the underlying pathogenesis of parathyroid disease. In addition to the classic characteristic features of parathyroid neoplasms, subtleties in histologic features which may indicate an underlying genetic abnormality reflect increased...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Endocrine pathology Ročník 33; číslo 1; s. 64 - 89
Hlavní autori:	Erickson, Lori A., Mete, Ozgur, Juhlin, C. Christofer, Perren, Aurel, Gill, Anthony J.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	New York Springer US 01.03.2022 Springer Nature B.V
Predmet:	Adenoma Blood clots Carcinoma Classification Endocrinology Hyperparathyroidism Hyperplasia Immunohistochemistry Medicine Medicine & Public Health Metastases Mitosis Neoplasia Neuroendocrine tumors Nucleoli Oncology Parathyroid Parathyroidectomy Pathogenesis Pathology Patients Renal failure Thrombosis Tumor cells Tumors Parathyroid hyperplasia Inherited hyperparathyroidism Parathyroid adenoma Atypical parathyroid tumor WHO classification Hyperparathyroidism Parathyroid carcinoma Multiglandular parathyroid disease Parafibromin
ISSN:	1046-3976, 1559-0097, 1559-0097
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!